Adaptimmune Therapeutics (ADAP.Q) announced today that it has entered into a strategic collaboration and license agreement with Genentech, a member of the Roche Group, to develop and commercialize allogenic…
Latest News
Bitcoin bulls beware! Topping pattern to trigger more downside?
Top 5 Gainers and Losers: NUMI.TO, FOBI.V, IDK.CN
Top 5 Gainers and Losers: COR.V, PGDC.V, LOT.V
Atco Mining and Standard Uranium show promising early uranium drill results
Standard Uranium (STND.V) intersects anomalous radioactivity
Top 5 Gainers and Losers: SVA.TO, BRM.V, COR.V